Target Gene/Pathway Pathway / Gene
Search results
Showing 1 to 9 of 9 entries
| No. | KEGG GENES | KEGG PATHWAY | KEGG DRUG | DrugBank | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
LILRA4
💬1. LILRA4
| 2件: Osteoclast differentiation Osteoclast differentiation, B cell receptor signaling pathway | Daxdilimab
Daxdilimab
💬1. LILRA4
| Daxdilimab | 2件: 49 49, 50 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 |
LCK
💬2. LCK
| 10件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Yersinia infection, Human T-cell leukemia virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency 10件: NF-kappa B signaling pathway, Osteoclast differentiation, Natural killer cell mediated cytotoxi ... | Dasatinib
Dasatinib
💬2. LCK
| Dasatinib | 2件: 51 51, 85 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 |
LCK
💬3. LCK
| 10件: NF-kappa B signaling pathway NF-kappa B signaling pathway, Osteoclast differentiation, Natural killer cell mediated cytotoxicity, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Yersinia infection, Human T-cell leukemia virus 1 infection, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency 10件: NF-kappa B signaling pathway, Osteoclast differentiation, Natural killer cell mediated cytotoxi ... | Dasatinib
Dasatinib
💬3. LCK
| Dasatinib | 2件: 51 51, 85 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 |
LEPR
💬4. LEPR
| 6件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, AMPK signaling pathway, JAK-STAT signaling pathway, Adipocytokine signaling pathway, Non-alcoholic fatty liver disease 6件: Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, AMPK signaling ... | Metreleptin
Metreleptin
💬4. LEPR
| Metreleptin | 1件: 265 265 💬4. LEPR
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 |
LIPA
💬5. LIPA
| 3件: Steroid biosynthesis Steroid biosynthesis, Lysosome, Cholesterol metabolism | Sebelipase alfa
Sebelipase alfa
💬5. LIPA
| Sebelipase alfa | 1件: 19 19 💬5. LIPA
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 |
LTA
💬6. LTA
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection 7件: Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine rec ... | Etanercept
Etanercept
💬6. LTA
| Etanercept | 16件: 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 💬6. LTA
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 |
LTA
💬7. LTA
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, NF-kappa B signaling pathway, TNF signaling pathway, Type I diabetes mellitus, Human T-cell leukemia virus 1 infection, Herpes simplex virus 1 infection 7件: Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine rec ... | Pateclizumab
Pateclizumab
💬7. LTA
| Pateclizumab | 1件: 46 46 💬7. LTA
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 |
LTB
💬8. LTB
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Rheumatoid arthritis | Baminercept
Baminercept
💬8. LTB
| Baminercept | 4件: 13 13, 46, 53, 97 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 |
LINGO1
💬9. LINGO1
| - | Opicinumab
Opicinumab
💬9. LINGO1
| Opicinumab | 1件: 13 13 💬9. LINGO1
|